行情

APOP

APOP

Cellect生物科技
NASDAQ

实时行情|Nasdaq Last Sale

2.920
+0.090
+3.18%
已收盘, 16:00 01/17 EST
开盘
2.870
昨收
2.830
最高
2.970
最低
2.870
成交量
10.31万
成交额
--
52周最高
19.15
52周最低
1.580
市值
8.71亿
市盈率(TTM)
--
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

APOP 新闻

  • 沪指下跌1.41% IMF上调2020年中国经济增长预期
  • 新浪财经.32分钟前
  • 3.5亿美元收购Uber Eats 印度外卖巨头Zomato的阳谋
  • 36氪.2小时前
  • 法国又要举白旗了?马克龙在美国压力下暂停数字税
  • 环球外汇网官网.2小时前
  • 瑞银未能实现2019年盈利目标 财富管理业务面临挑战
  • 新浪美股.3小时前

更多

所属板块

生物技术和医学研究
-0.16%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

APOP 简况

Cellect Biotechnology Ltd is an Israel-based biotechnology company. Its technology platform, ApoGraft, selects stem cells to improve the safety and efficacy of regenerative medicine and cell therapies by using functional selection. Efficient selection enables retention of most of the stem cells while neutralizing harmful mature cells. ApoGraft exploit a functional characteristic of stem cells relating to apoptosis, which is the process of programmed cell death and is a vital part of physiological development and homeostasis of all organisms. Stem cells flourish in an environment where normal cells die because their main role is reconstitution of damaged tissue. The platform is being tested for clinical use in allogeneic hematopoietic stem cell transplantation (HSCT) for the treatment of hematological malignancies. Additionally, the Company is developing its first product based on its platform, the ApoTainer selection kit that utilizes FasL-coated paramagnetic beads.
展开

Webull提供Cellect Biotechnology Ltd - ADR的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。